Home Subscriber Only GenoPalate completes $4 million funding round

GenoPalate completes $4 million funding round

By
Andrew Weiland
-
Sherry Zhang
GenoPalate founder and CEO Sherry Zhang Credit: Jake Hill

Wauwatosa-based GenoPalate, Inc., an early-stage nutritional genomics company, announced that it has completed a $4 million round of equity financing from local investors. This is the third round of funding for the company. The funds will be used to expand the capacity of GenoPalate’s internet platform, which the company says will more than double its

Already a subscriber? Log in

To continue reading this article ...

Subscribe to BizTimes today and get immediate access to our Insider-only content and much more.

Learn More and Subscribe Now
  • Critical Milwaukee and Southeastern Wisconsin business news and analysis updated daily.
  • 16 issues per year delivered in print or digitally
  • Unlimited access to all insider only content on our website, on any device.
  • Free email alerts.
  • Extra bonus issues (STUFF and Giving Guide)
  • Discounted in-person event registration

Click here to purchase a sharable paywall bypass link for this subscriber-only article.

Andrew Weiland
Andrew is the editor of BizTimes Milwaukee. He joined BizTimes in 2003, serving as managing editor and real estate reporter for 11 years. A University of Wisconsin-Madison graduate, he is a lifelong resident of the state. He lives in Muskego with his wife, Seng, their son, Zach, and their dog, Hokey. He is an avid sports fan, a member of the Muskego Athletic Association board of directors and commissioner of the MAA's high school rec baseball league.
Linkedin Mail Twitter

RELATED ARTICLES

Copyright ©2024 BizTimes Media, LLC. All Rights Reserved.
Wauwatosa-based GenoPalate, Inc., an early-stage nutritional genomics company, announced that it has completed a $4 million round of equity financing from local investors. This is the third round of funding for the company. The funds will be used to expand the capacity of GenoPalate’s internet platform, which the company says will more than double its current capacity. GenoPalate is a provider of nutrigenomics testing and analytical services to help consumers make healthy dietary choices. Using proprietary algorithms, GenoPalate interprets the customer’s DNA to help determine a personalized nutrition profile that shows them which foods are good and bad for their health. In addition to internet platform development, the funds will be used to expand digital marketing and to continue the development of research databases for addressing personalized nutrition, health and wellness, and chronic metabolic diseases such as type-2 diabetes, obesity, and metabolic syndrome, the company said. “To truly eat healthy and apply daily food behavior to preventing chronic metabolic diseases, one must personalize his or her nutrition. Genomics is key to our understanding of anyone's food personalization for health,” said chief executive officer Sherry Zhang, a geneticist who founded GenoPalate in 2016.

Stay up-to-date with our free email newsletter

Keep up with the issues, companies and people that matter most to business in the Milwaukee metro area.

By subscribing you agree to our privacy policy.

No, thank you.
Exit mobile version